Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous Fluoride Dentifrice for Dentinal Hypersensitivity
NCT03072719Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2012
- Primary completion
- Jun 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of stannous fluoride in Dentinal hypersensitivity (DH) (2 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Schiff Sensitivity Score at Day 14. Started Mar 2012; status: completed.
02
Drugs
stannous fluoride
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on NCT03072719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072719.